UNSPSC 85501411: Restriction of left internal carotid artery with extraluminal device, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to restriction of left internal carotid artery with extraluminal device, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 03VL4CZ

UNSPSC 85501411 Restriction of left internal carotid artery with extraluminal device, percutaneous endoscopic approach is a Commodity code that shows no relevant recent state and local procurement activity. The code names a specific surgical procedure code drawn from clinical taxonomy rather than a product or service family that state and local jurisdictions routinely purchase as a standalone good or service. Recent opportunities tagged to this code do not involve the procedure itself; instead, they represent medical services procurement across entirely different functional areas — independent medical evaluations for pension disability determinations, health plan carve-out networks, occupational medical surveillance, youth detention healthcare, pharmacy benefit management, and temporary clinical staffing — none of which align with the carotid artery restriction procedure the code nominally describes.

The mismatch between code and opportunity content suggests either miscoding by issuing bodies or a data alignment issue rather than genuine market activity under this commodity. Firms evaluating this code should verify actual procurement requirements directly with issuing jurisdictions before pursuing, as the tagged opportunities do not reflect meaningful purchasing patterns for the procedure named in the code. The geographic and issuing-body distribution of the recent postings spans Arizona, California, Washington, Texas, and Florida across municipal, county, and state health system buyers, but that diversity reflects the unrelated nature of the opportunities rather than a coherent market segment for this specific clinical procedure.